← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2009Last known activity
Mar 10, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05780554Lead sponsorN/AMar 10, 2023
- NCT05780554Reponsible party - principal investigatorN/AMar 10, 2023
- NCT04357106CollaboratorPhase 2Apr 13, 2020
- NCT04357106Reponsible party - principal investigatorPhase 2Apr 13, 2020
- NCT04357106Lead sponsorPhase 2Apr 13, 2020
- NCT02439879Overall official - principal investigatorPhase 4Dec 1, 2009
- NCT02439879Reponsible party - principal investigatorPhase 4Dec 1, 2009
- NCT02439879Lead sponsorPhase 4Dec 1, 2009
Details
- Last known activity
- Mar 10, 2023